• Info
  • Insider Ownership

Insider Trading & Ownership of JOHN JOHNSON

Location
Seattle, WA
Summary
The estimated net worth of JOHN JOHNSON is at least $8.07M dollars as of 19 Dec 2025. JOHN JOHNSON is the Director of Xeris Biopharma Holdings, Inc. and owns shares of Xeris Biopharma Holdings, Inc. (XERS) stock worth about $5.04M. JOHN JOHNSON is the Executive Chairman, Director of Applied Therapeutics, Inc. and owns shares of Applied Therapeutics, Inc. (APLT) stock worth about $2.92M. JOHN JOHNSON is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $116K.
Signature
/s/ Beth Hecht, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when JOHN JOHNSON files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of JOHN JOHNSON

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
XERS Xeris Biopharma Holdings, Inc. Director $5.04M -$1.76M -25.9% 19 Dec 2025
APLT Applied Therapeutics, Inc. Executive Chairman, Director $2.92M 19 Dec 2024
VSTM Verastem, Inc. Director $116K 22 May 2025
AXGN Axogen, Inc. Director $0 -$1.43M -100% 08 Dec 2025
SBBP Strongbridge Biopharma plc Chief Executive Officer, Director 05 Oct 2021

Insider Transactions Reported by JOHN JOHNSON:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.